APA (7th ed.) Citation

T, S., G, C., J, D., T, M., N, G., J, F., . . . F, S. (2026). Non-ICANS neurotoxicities CD19-directed CAR T-cell therapy and the emergence of movement and neurocognitive treatment-emergent adverse events: A case report. Frontiers in immunology, 17, 1749587. https://doi.org/10.3389/fimmu.2026.1749587

Chicago Style (17th ed.) Citation

T, Schroeder, et al. "Non-ICANS Neurotoxicities CD19-directed CAR T-cell Therapy and the Emergence of Movement and Neurocognitive Treatment-emergent Adverse Events: A Case Report." Frontiers in Immunology 17 (2026): 1749587. https://doi.org/10.3389/fimmu.2026.1749587.

MLA (9th ed.) Citation

T, Schroeder, et al. "Non-ICANS Neurotoxicities CD19-directed CAR T-cell Therapy and the Emergence of Movement and Neurocognitive Treatment-emergent Adverse Events: A Case Report." Frontiers in Immunology, vol. 17, 2026, p. 1749587, https://doi.org/10.3389/fimmu.2026.1749587.